Free preview. Sign up free to see the team, full portfolio, ownership chain, and shareholding history.
Glaxo Group Limited investment portfolio
Glaxo Group Limited has made numerous investments in companies such as Sitryx Therapeutics, Nerre Therapeutics Holdings, and Apollo Therapeutics Group within the Healthcare & Life Sciences sector.
corporate
Portfolio
3
Team
0
Portfolio (3)
| Company | Sector | City | Source | Last confirmed on |
|---|---|---|---|---|
| Apollo Therapeutics Group Limited Apollo Therapeutics Group Limited is a portfolio biopharmaceutical company that translates breakthroughs in biology and basic medical research into innovative medicines, managing over 20 therapeutic programs with six in development. It focuses on developing first‑ or best‑in‑class treatments for serious diseases through a scalable R&D platform and partnerships with leading universities. | — | Cambridge | Confirmed | 2026-05-12 |
| Nerre Therapeutics Holdings Limited | Healthcare & Life Sciences | Cambridge | Confirmed | 2026-02-26 |
Backs Similar Companies
Investors who tend to invest in the same sort of companies.
5 more similar investors hiddenSign up to unlock →
Shareholding changes (3)
Glaxo Group Limited's positions across portfolio companies2025
- SERIES A PREFERRED SHARES 3,564,002 → 3,753,919
2024
- SERIES A PREFERRED SHARES 3,247,473 → 3,564,002